Global pharmaceutical giant signs deal with Yorkshire specialist
Dienstag, 14 Juli 2009
Merck Serono will use the 'Cool Click 2' product for self-injection of its growth hormone Saizen which is used to treat growth hormone deficiency in adults and children.
Sheffield-based The Medical House said the device contains a number of new features including an innovative dose display, an enhanced security system for safe injection and a lower level of noise made during the injection.
Ian Townsend, chief executive of the Sheffield business, said: "I am extremely delighted to report that this new technology is now being launched commercially; it is the result of a great deal of hard work by the staff at The Medical House and Merck Serono.
"I believe that this will prove to be a significant landmark in the progression of our company as a global player in the drug delivery market and we look forward to supplying the healthcare industry with devices and consumables for many years to come."
Yorkshire has one of the highest concentrations of medical and healthcare firms in the world and the added benefit of cutting edge research and development (R&D) through its network of universities and research organisations.
Overseas healthcare businesses benefit from this R&D expertise through collaboration on healthcare projects. Traditionally, the US and other foreign companies have selected the UK as their European operational base as it represents a gateway to the rest of Europe.